首页 > 最新文献

Journal of Critical Care Medicine最新文献

英文 中文
The Impact of Prenatal Diagnosis in the Evolution of Newborns with Congenital Heart Disease. 产前诊断对新生儿先天性心脏病演变的影响
IF 1.1 Pub Date : 2023-01-01 DOI: 10.2478/jccm-2023-0007
Daniela Toma, Elena Moldovan, Liliana Gozar

Congenital heart malformations are cardiac and/or vascular structural abnormalities that appear before birth, the majority of which can be detected prenatally. The latest data from the literature were reviewed, with reference to the degree of prenatal diagnosis regarding congenital heart malformations, as well as its impact on the preoperative evolution and implicitly on mortality. Studies with a significant number of enrolled patients were included in the research. Prenatal congenital heart malformations detection rates were different, depending on the period in which the study took place, the level of the medical center, as well as on the size of enrolled groups. Prenatal diagnosis in critical malformations such as hypoplastic left heart syndrome, transposition of great arteries and totally aberrant pulmonary venous drainage has proven its usefulness, allowing an early surgical intervention, thus ensuring improved neurological development, increasing the survival rate and decreasing the rate of subsequent complications. Sharing the experience and results obtained by each individual therapeutic center will definitely lead to drawing clear conclusions regarding the clinical contribution of congenital heart malformations prenatal detection.

先天性心脏畸形是在出生前出现的心脏和/或血管结构异常,其中大多数可以在产前检测到。本文回顾了最新的文献资料,参考了先天性心脏畸形的产前诊断程度,以及其对术前进展和隐性死亡率的影响。研究纳入了大量入组患者。产前先天性心脏畸形的检出率是不同的,这取决于研究进行的时间,医疗中心的水平,以及登记组的规模。产前诊断严重畸形如左心发育不全综合征、大动脉转位和肺静脉引流完全异常已被证明是有用的,允许早期手术干预,从而确保改善神经发育,提高生存率和减少后续并发症的发生率。分享每个治疗中心的经验和结果,一定会对先天性心脏畸形产前检测的临床贡献得出明确的结论。
{"title":"The Impact of Prenatal Diagnosis in the Evolution of Newborns with Congenital Heart Disease.","authors":"Daniela Toma,&nbsp;Elena Moldovan,&nbsp;Liliana Gozar","doi":"10.2478/jccm-2023-0007","DOIUrl":"https://doi.org/10.2478/jccm-2023-0007","url":null,"abstract":"<p><p>Congenital heart malformations are cardiac and/or vascular structural abnormalities that appear before birth, the majority of which can be detected prenatally. The latest data from the literature were reviewed, with reference to the degree of prenatal diagnosis regarding congenital heart malformations, as well as its impact on the preoperative evolution and implicitly on mortality. Studies with a significant number of enrolled patients were included in the research. Prenatal congenital heart malformations detection rates were different, depending on the period in which the study took place, the level of the medical center, as well as on the size of enrolled groups. Prenatal diagnosis in critical malformations such as hypoplastic left heart syndrome, transposition of great arteries and totally aberrant pulmonary venous drainage has proven its usefulness, allowing an early surgical intervention, thus ensuring improved neurological development, increasing the survival rate and decreasing the rate of subsequent complications. Sharing the experience and results obtained by each individual therapeutic center will definitely lead to drawing clear conclusions regarding the clinical contribution of congenital heart malformations prenatal detection.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9081326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of Critical Care Ultrasonography Plus Arterial Blood Gas Analysis Based Algorithm in Diagnosing Aetiology of Acute Respiratory Failure. 危重病超声加动脉血气分析诊断急性呼吸衰竭的准确性。
IF 1.1 Pub Date : 2023-01-01 DOI: 10.2478/jccm-2023-0006
Rajesh Panda, Saurabh Saigal, Rajnish Joshi, Abhijit Pakhare, Ankur Joshi, Jai Prakash Sharma, Sahil Tandon

Introduction: Lung ultrasound when used in isolation, usually misses out metabolic causes of dyspnoea and differentiating acute exacerbation of COPD from pneumonia and pulmonary embolism is difficult, hence we thought of combining critical care ultrasonography (CCUS) with arterial blood gas analysis (ABG).

Aim of the study: The objective of this study was to estimate accuracy of Critical Care Ultrasonography (CCUS) plus Arterial blood gas (ABG) based algorithm in diagnosing aetiology of dyspnoea. Accuracy of traditional Chest X-ray (CxR) based algorithm was also validated in the following setting.

Methods: It was a facility based comparative study, where 174 dyspneic patients were subjected to CCUS plus ABG and CxR based algorithms on admission to ICU. The patients were classified into one of five pathophysiological diagnosis 1) Alveolar( Lung-pneumonia)disorder ; 2) Alveolar (Cardiac-pulmonary edema) disorder; 3) Ventilation with Alveolar defect (COPD) disorder ;4) Perfusion disorder; and 5) Metabolic disorder. We calculated diagnostic test properties of CCUS plus ABG and CXR based algorithm in relation to composite diagnosis and correlated these algorithms for each of the defined pathophysiological diagnosis.

Results: The sensitivity of CCUS and ABG based algorithm was 0.85 (95% CI-75.03-92.03) for alveolar (lung) ; 0.94 (95% CI-85.15-98.13) for alveolar (cardiac); 0.83 (95% CI-60.78-94.16) for ventilation with alveolar defect; 0.66 (95% CI-30-90.32) for perfusion defect; 0.63 (95% CI-45.25-77.07) for metabolic disorders.Cohn's kappa correlation coefficient of CCUS plus ABG based algorithm in relation to composite diagnosis was 0.7 for alveolar (lung), 0.85 for alveolar (cardiac), 0.78 for ventilation with alveolar defect, 0.79 for perfusion defect and 0.69 for metabolic disorders.

Conclusion: CCUS plus ABG algorithm is highly sensitive and it's agreement with composite diagnosis is far superior. It is a first of it's kind study, where authors have attempted combining two point of care tests and creating an algorithmic approach for timely diagnosis and intervention.

肺部超声在单独使用时,通常会遗漏呼吸困难的代谢性原因,并且难以区分COPD急性加重与肺炎和肺栓塞,因此我们考虑将重症监护超声(CCUS)与动脉血气分析(ABG)结合使用。研究目的:本研究的目的是评估危重监护超声(CCUS)加动脉血气(ABG)算法诊断呼吸困难病因学的准确性。在以下情况下,也验证了传统基于胸部x线(CxR)的算法的准确性。方法:对174例呼吸困难患者在ICU入院时进行CCUS + ABG和CxR算法的对比研究。患者的病理生理诊断分为5种:1)肺泡(肺-肺炎)疾病;肺泡(心肺水肿)紊乱;3)肺泡缺损通气(COPD)障碍;4)灌注障碍;5)代谢紊乱。我们计算了CCUS + ABG和基于CXR的算法与复合诊断的诊断测试特性,并将这些算法与每种定义的病理生理诊断相关联。结果:基于CCUS和ABG的算法对肺泡(肺)的敏感性为0.85 (95% CI-75.03-92.03);肺泡(心脏)0.94 (95% CI-85.15-98.13);通气伴肺泡缺损0.83 (95% CI-60.78-94.16);灌注缺损0.66 (95% CI-30-90.32);0.63 (95% CI-45.25-77.07)。CCUS + ABG算法与肺泡(肺)、肺泡(心)、通气伴肺泡缺损、灌注缺损、代谢紊乱的Cohn’s kappa相关系数分别为0.7、0.85、0.78、0.79和0.69。结论:CCUS + ABG算法具有较高的敏感性,与综合诊断的符合性要好得多。这是同类研究中的第一个,作者尝试将两个护理点测试结合起来,并创建了一种及时诊断和干预的算法方法。
{"title":"Accuracy of Critical Care Ultrasonography Plus Arterial Blood Gas Analysis Based Algorithm in Diagnosing Aetiology of Acute Respiratory Failure.","authors":"Rajesh Panda,&nbsp;Saurabh Saigal,&nbsp;Rajnish Joshi,&nbsp;Abhijit Pakhare,&nbsp;Ankur Joshi,&nbsp;Jai Prakash Sharma,&nbsp;Sahil Tandon","doi":"10.2478/jccm-2023-0006","DOIUrl":"https://doi.org/10.2478/jccm-2023-0006","url":null,"abstract":"<p><strong>Introduction: </strong>Lung ultrasound when used in isolation, usually misses out metabolic causes of dyspnoea and differentiating acute exacerbation of COPD from pneumonia and pulmonary embolism is difficult, hence we thought of combining critical care ultrasonography (CCUS) with arterial blood gas analysis (ABG).</p><p><strong>Aim of the study: </strong>The objective of this study was to estimate accuracy of Critical Care Ultrasonography (CCUS) plus Arterial blood gas (ABG) based algorithm in diagnosing aetiology of dyspnoea. Accuracy of traditional Chest X-ray (CxR) based algorithm was also validated in the following setting.</p><p><strong>Methods: </strong>It was a facility based comparative study, where 174 dyspneic patients were subjected to CCUS plus ABG and CxR based algorithms on admission to ICU. The patients were classified into one of five pathophysiological diagnosis 1) Alveolar( Lung-pneumonia)disorder ; 2) Alveolar (Cardiac-pulmonary edema) disorder; 3) Ventilation with Alveolar defect (COPD) disorder ;4) Perfusion disorder; and 5) Metabolic disorder. We calculated diagnostic test properties of CCUS plus ABG and CXR based algorithm in relation to composite diagnosis and correlated these algorithms for each of the defined pathophysiological diagnosis.</p><p><strong>Results: </strong>The sensitivity of CCUS and ABG based algorithm was 0.85 (95% CI-75.03-92.03) for alveolar (lung) ; 0.94 (95% CI-85.15-98.13) for alveolar (cardiac); 0.83 (95% CI-60.78-94.16) for ventilation with alveolar defect; 0.66 (95% CI-30-90.32) for perfusion defect; 0.63 (95% CI-45.25-77.07) for metabolic disorders.Cohn's kappa correlation coefficient of CCUS plus ABG based algorithm in relation to composite diagnosis was 0.7 for alveolar (lung), 0.85 for alveolar (cardiac), 0.78 for ventilation with alveolar defect, 0.79 for perfusion defect and 0.69 for metabolic disorders.</p><p><strong>Conclusion: </strong>CCUS plus ABG algorithm is highly sensitive and it's agreement with composite diagnosis is far superior. It is a first of it's kind study, where authors have attempted combining two point of care tests and creating an algorithmic approach for timely diagnosis and intervention.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9075305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain Tissue Oxygen Levels as a Perspective Therapeutic Target in Traumatic Brain Injury. Retrospective Cohort Study. 脑组织氧水平作为创伤性脑损伤的治疗靶点。回顾性队列研究。
IF 1.1 Pub Date : 2023-01-01 DOI: 10.2478/jccm-2023-0001
Gal Roman, Ondrej Hrdy, Kamil Vrbica, Jan Hudec, Andrej Mrlian, Martin Smrcka

Introduction: Management of traumatic brain injury (TBI) requires a multidisciplinary approach and represents a significant challenge for both neurosurgeons and intensivists. The role of brain tissue oxygenation (PbtO2) monitoring and its impact on posttraumatic outcomes remains a controversial topic.

Aim of the study: Our study aimed to evaluate the impact of PbtO2 monitoring on mortality, 30 days and 6 months neurological outcomes in patients with severe TBI compared with those resulting from standard intracranial pressure (ICP) monitoring.

Material and methods: In this retrospective cohort study, we analysed the outcomes of 77 patients with severe TBI who met the inclusion criteria. These patients were divided into two groups, including 37 patients who were managed with ICP and PbtO2 monitoring protocols and 40 patients who were managed using ICP protocols alone.

Results: There were no significant differences in demographic data between the two groups. We found no statistically significant differences in mortality or Glasgow Outcome Scale (GOS) scores one month after TBI. However, our results revealed that GOS scores at 6 months had improved significantly among patients managed with PbtO2; this finding was particularly notable for Glasgow Outcome Scale (GOS) scores of 4-5. Close monitoring and management of reductions in PbtO2, particularly by increasing the fraction of inspired oxygen, was associated with higher partial pressures of oxygen in this group.

Conclusions: Monitoring of PbtO2 may facilitate the appropriate evaluation and treatment of low PbtO2 and represents a promising tool for the management of patients with severe TBI. Additional studies will be needed to confirm these findings.

简介:创伤性脑损伤(TBI)的治疗需要多学科的方法,这对神经外科医生和重症监护医生都是一个重大的挑战。脑组织氧合(PbtO2)监测的作用及其对创伤后预后的影响仍然是一个有争议的话题。研究目的:我们的研究旨在评估PbtO2监测与标准颅内压(ICP)监测相比对严重TBI患者死亡率、30天和6个月神经系统预后的影响。材料和方法:在这项回顾性队列研究中,我们分析了77例符合纳入标准的严重TBI患者的结局。这些患者被分为两组,其中37例患者采用ICP和PbtO2监测方案管理,40例患者仅采用ICP方案管理。结果:两组患者人口学资料差异无统计学意义。我们发现TBI后一个月的死亡率或格拉斯哥预后量表(GOS)评分没有统计学上的显著差异。然而,我们的结果显示,在PbtO2治疗的患者中,GOS评分在6个月时显著改善;这一发现对于格拉斯哥结局量表(GOS) 4-5分的得分尤为显著。密切监测和管理PbtO2的减少,特别是通过增加吸入氧的比例,与该组较高的氧分压有关。结论:监测PbtO2可能有助于对低PbtO2患者进行适当的评估和治疗,是治疗严重TBI患者的一种有前景的工具。需要进一步的研究来证实这些发现。
{"title":"Brain Tissue Oxygen Levels as a Perspective Therapeutic Target in Traumatic Brain Injury. Retrospective Cohort Study.","authors":"Gal Roman,&nbsp;Ondrej Hrdy,&nbsp;Kamil Vrbica,&nbsp;Jan Hudec,&nbsp;Andrej Mrlian,&nbsp;Martin Smrcka","doi":"10.2478/jccm-2023-0001","DOIUrl":"https://doi.org/10.2478/jccm-2023-0001","url":null,"abstract":"<p><strong>Introduction: </strong>Management of traumatic brain injury (TBI) requires a multidisciplinary approach and represents a significant challenge for both neurosurgeons and intensivists. The role of brain tissue oxygenation (PbtO2) monitoring and its impact on posttraumatic outcomes remains a controversial topic.</p><p><strong>Aim of the study: </strong>Our study aimed to evaluate the impact of PbtO2 monitoring on mortality, 30 days and 6 months neurological outcomes in patients with severe TBI compared with those resulting from standard intracranial pressure (ICP) monitoring.</p><p><strong>Material and methods: </strong>In this retrospective cohort study, we analysed the outcomes of 77 patients with severe TBI who met the inclusion criteria. These patients were divided into two groups, including 37 patients who were managed with ICP and PbtO2 monitoring protocols and 40 patients who were managed using ICP protocols alone.</p><p><strong>Results: </strong>There were no significant differences in demographic data between the two groups. We found no statistically significant differences in mortality or Glasgow Outcome Scale (GOS) scores one month after TBI. However, our results revealed that GOS scores at 6 months had improved significantly among patients managed with PbtO2; this finding was particularly notable for Glasgow Outcome Scale (GOS) scores of 4-5. Close monitoring and management of reductions in PbtO2, particularly by increasing the fraction of inspired oxygen, was associated with higher partial pressures of oxygen in this group.</p><p><strong>Conclusions: </strong>Monitoring of PbtO2 may facilitate the appropriate evaluation and treatment of low PbtO2 and represents a promising tool for the management of patients with severe TBI. Additional studies will be needed to confirm these findings.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9075312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Lactate Clearance as a Determinant of Survival in Patients with Sepsis: Findings from a Low-resource Country. 早期乳酸清除率作为脓毒症患者生存的决定因素:来自资源匮乏国家的研究结果。
IF 1.1 Pub Date : 2023-01-01 DOI: 10.2478/jccm-2023-0005
Fazal Rehman, Saad Bin Zafar, Adil Aziz, Abdul Aziz, Pirbhat Shams Memon, Taymmia Ejaz, Summaira Aziz

Background: Single lactate measurements have been reported to have prognostic significance, however, there is a lack of data in local literature from Pakistan. This study was done to determine prognostic role of lactate clearance in sepsis patients being managed in our lower-middle income country.

Methods: This prospective cohort study was conducted from September 2019-February 2020 at the Aga Khan University Hospital, Karachi. Patients were enrolled using consecutive sampling and categorized based on their lactate clearance status. Lactate clearance was defined as decrease by 10% or greater in repeat lactate from the initial measurement (or both initial and repeat levels <=2.0 mmol/L).

Results: A total 198 patients were included in the study, 51% (101) were male. Multi-organ dysfunction was reported in 18.6% (37), 47.7% (94) had single organ dysfunction, and 33.8% (67) had no organ dysfunction. Around 83% (165) were discharged and 17% (33) died. There were missing data for 25.8% (51) of the patients for the lactate clearance, whereas 55% (108) patients had early lactate clearance and 19.7% (39) had delayed lactate clearance.On univariate analysis, mortality rate was higher in patients with delayed lactate clearance (38.4% vs 16.6%) and patients were 3.12 times (OR = 3.12; [95% CI: 1.37-7.09]) more likely to die as compared with early lactate clearance. Patients with delayed lactate clearance had higher organ dysfunction (79.4% vs 60.1%) and were 2.56 (OR = 2.56; [95% CI: 1.07-6.13]) times likely to have organ dysfunction. On multivariate analysis, after adjusting for age and co-morbids, patients with delayed lactate clearance were 8 times more likely to die than patients with early lactate clearance [aOR = 7.67; 95% CI:1.11-53.26], however, there was no statistically significant association between delayed lactate clearance [aOR = 2.18; 95% CI: 0.87-5.49)] and organ dysfunction.

Conclusion: Lactate clearance is a better determinant of sepsis and septic shock effective management. Early lactate clearance is related to better outcomes in septic patients.

背景:据报道,单乳酸测量具有预后意义,然而,在巴基斯坦的当地文献中缺乏数据。本研究旨在确定在我国中低收入国家接受治疗的脓毒症患者乳酸清除率的预后作用。方法:这项前瞻性队列研究于2019年9月至2020年2月在卡拉奇阿迦汗大学医院进行。患者采用连续抽样,并根据其乳酸清除状态进行分类。乳酸清除率定义为与初始测量(或初始和重复水平)相比,重复乳酸减少10%或更多。结果:研究共纳入198例患者,51%(101)为男性。多脏器功能障碍37例(18.6%),单脏器功能障碍94例(47.7%),无脏器功能障碍67例(33.8%)。约83%(165例)出院,17%(33例)死亡。25.8%(51)的患者缺少乳酸清除率数据,而55%(108)的患者有早期乳酸清除率,19.7%(39)的患者有延迟乳酸清除率。单因素分析显示,乳酸清除率延迟的患者死亡率更高(38.4% vs 16.6%),死亡率为3.12倍(OR = 3.12;[95% CI: 1.37-7.09])与早期乳酸清除率相比更容易死亡。乳酸清除延迟的患者有更高的器官功能障碍(79.4% vs 60.1%),分别为2.56 (OR = 2.56;[95% CI: 1.07-6.13])有器官功能障碍的可能性。在多因素分析中,在调整年龄和合病后,乳酸清除延迟患者的死亡率是乳酸清除早期患者的8倍[aOR = 7.67;95% CI:1.11-53.26],然而,延迟乳酸清除率与延迟乳酸清除率之间无统计学意义的相关性[aOR = 2.18;95% CI: 0.87-5.49)]和器官功能障碍。结论:乳酸清除率是脓毒症和脓毒性休克有效治疗的较好决定因素。早期乳酸清除与脓毒症患者更好的预后相关。
{"title":"Early Lactate Clearance as a Determinant of Survival in Patients with Sepsis: Findings from a Low-resource Country.","authors":"Fazal Rehman,&nbsp;Saad Bin Zafar,&nbsp;Adil Aziz,&nbsp;Abdul Aziz,&nbsp;Pirbhat Shams Memon,&nbsp;Taymmia Ejaz,&nbsp;Summaira Aziz","doi":"10.2478/jccm-2023-0005","DOIUrl":"https://doi.org/10.2478/jccm-2023-0005","url":null,"abstract":"<p><strong>Background: </strong>Single lactate measurements have been reported to have prognostic significance, however, there is a lack of data in local literature from Pakistan. This study was done to determine prognostic role of lactate clearance in sepsis patients being managed in our lower-middle income country.</p><p><strong>Methods: </strong>This prospective cohort study was conducted from September 2019-February 2020 at the Aga Khan University Hospital, Karachi. Patients were enrolled using consecutive sampling and categorized based on their lactate clearance status. Lactate clearance was defined as decrease by 10% or greater in repeat lactate from the initial measurement (or both initial and repeat levels <=2.0 mmol/L).</p><p><strong>Results: </strong>A total 198 patients were included in the study, 51% (101) were male. Multi-organ dysfunction was reported in 18.6% (37), 47.7% (94) had single organ dysfunction, and 33.8% (67) had no organ dysfunction. Around 83% (165) were discharged and 17% (33) died. There were missing data for 25.8% (51) of the patients for the lactate clearance, whereas 55% (108) patients had early lactate clearance and 19.7% (39) had delayed lactate clearance.On univariate analysis, mortality rate was higher in patients with delayed lactate clearance (38.4% vs 16.6%) and patients were 3.12 times (OR = 3.12; [95% CI: 1.37-7.09]) more likely to die as compared with early lactate clearance. Patients with delayed lactate clearance had higher organ dysfunction (79.4% vs 60.1%) and were 2.56 (OR = 2.56; [95% CI: 1.07-6.13]) times likely to have organ dysfunction. On multivariate analysis, after adjusting for age and co-morbids, patients with delayed lactate clearance were 8 times more likely to die than patients with early lactate clearance [aOR = 7.67; 95% CI:1.11-53.26], however, there was no statistically significant association between delayed lactate clearance [aOR = 2.18; 95% CI: 0.87-5.49)] and organ dysfunction.</p><p><strong>Conclusion: </strong>Lactate clearance is a better determinant of sepsis and septic shock effective management. Early lactate clearance is related to better outcomes in septic patients.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9075306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Caffeine Citrate for Respiratory Stimulation in Acquired Central Hypoventilation Syndrome: A Case Series. 使用枸橼酸咖啡因刺激获得性中枢性低通气综合征的呼吸:一个病例系列。
IF 1.1 Pub Date : 2023-01-01 DOI: 10.2478/jccm-2023-0003
Pei Ling Tan, Chuan Poh Lim, Sharon Ong, Geoffrey Sithamparapillai Samuel

Introductions: Caffeine is commonly used as a respiratory stimulant for the treatment of apnea of prematurity in neonates. However, there are no reports to date of caffeine used to improve respiratory drive in adult patients with acquired central hypoventilation syndrome (ACHS).

Presentation of case series: We report two cases of ACHS who were successfully liberated from mechanical ventilation after caffeine use, without side effects. The first case was a 41-year-old ethnic Chinese male, diagnosed with high-grade astrocytoma in the right hemi-pons, intubated and admitted to the intensive care unit (ICU) in view of central hypercapnia with intermittent apneic episodes. Oral caffeine citrate (1600mg loading followed by 800mg once daily) was initiated. His ventilator support was weaned successfully after 12 days. The second case was a 65-year-old ethnic Indian female, diagnosed with posterior circulation stroke. She underwent posterior fossa decompressive craniectomy and insertion of an extra-ventricular drain. Post-operatively, she was admitted to the ICU and absence of spontaneous breath was observed for 24 hours. Oral caffeine citrate (300mg twice daily) was initiated and she regained spontaneous breath after 2 days of treatment. She was extubated and discharged from the ICU.

Conclusion: Oral caffeine was an effective respiratory stimulant in the above patients with ACHS. Larger randomized controlled studies are needed to determine its efficacy in the treatment of ACHS in adult patients.

简介:咖啡因是一种常用的呼吸兴奋剂,用于治疗早产儿呼吸暂停。然而,迄今为止还没有关于咖啡因用于改善成人获得性中枢性低通气综合征(ACHS)患者呼吸驱动的报道。病例系列的介绍:我们报告了两例ACHS患者,他们在咖啡因使用后成功地从机械通气中解放出来,没有副作用。第一例患者是一名41岁的华裔男性,诊断为右半桥高级别星形细胞瘤,因中枢性高碳酸血症伴间歇性呼吸暂停发作而插管并入住重症监护病房(ICU)。开始口服枸橼酸咖啡因(1600毫克,800mg,每日一次)。12天后,他的呼吸机支持成功断开。第二例为65岁的印度裔女性,诊断为后循环卒中。她接受了后颅窝减压术和插入脑室外引流管。术后入住ICU,观察无自主呼吸24小时。开始口服枸橼酸咖啡因(300mg,每日2次),治疗2天后恢复自主呼吸。她拔管出院。结论:口服咖啡因是一种有效的呼吸兴奋剂。需要更大规模的随机对照研究来确定其对成人患者的治疗效果。
{"title":"The Use of Caffeine Citrate for Respiratory Stimulation in Acquired Central Hypoventilation Syndrome: A Case Series.","authors":"Pei Ling Tan,&nbsp;Chuan Poh Lim,&nbsp;Sharon Ong,&nbsp;Geoffrey Sithamparapillai Samuel","doi":"10.2478/jccm-2023-0003","DOIUrl":"https://doi.org/10.2478/jccm-2023-0003","url":null,"abstract":"<p><strong>Introductions: </strong>Caffeine is commonly used as a respiratory stimulant for the treatment of apnea of prematurity in neonates. However, there are no reports to date of caffeine used to improve respiratory drive in adult patients with acquired central hypoventilation syndrome (ACHS).</p><p><strong>Presentation of case series: </strong>We report two cases of ACHS who were successfully liberated from mechanical ventilation after caffeine use, without side effects. The first case was a 41-year-old ethnic Chinese male, diagnosed with high-grade astrocytoma in the right hemi-pons, intubated and admitted to the intensive care unit (ICU) in view of central hypercapnia with intermittent apneic episodes. Oral caffeine citrate (1600mg loading followed by 800mg once daily) was initiated. His ventilator support was weaned successfully after 12 days. The second case was a 65-year-old ethnic Indian female, diagnosed with posterior circulation stroke. She underwent posterior fossa decompressive craniectomy and insertion of an extra-ventricular drain. Post-operatively, she was admitted to the ICU and absence of spontaneous breath was observed for 24 hours. Oral caffeine citrate (300mg twice daily) was initiated and she regained spontaneous breath after 2 days of treatment. She was extubated and discharged from the ICU.</p><p><strong>Conclusion: </strong>Oral caffeine was an effective respiratory stimulant in the above patients with ACHS. Larger randomized controlled studies are needed to determine its efficacy in the treatment of ACHS in adult patients.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9075309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ramping Position to Aid Non-invasive Ventilation (NIV) in Obese Patients in the ICU. 倾斜体位对ICU肥胖患者无创通气(NIV)的帮助。
IF 1.1 Pub Date : 2023-01-01 DOI: 10.2478/jccm-2023-0002
Mohamed Shirazy, Christopher Gowers, Padraig Headley

Introduction: The ramping position is recommended to facilitate pre-oxygenation and mask ventilation of obese patients in anaesthetics via improving the airway alignment.

Presentation of case series: Two cases of obese patients admitted to the intensive care unit (ICU) with type 2 respiratory failure. Both cases showed obstructive breathing patterns on non-invasive ventilation (NIV) and failed resolution of hypercapnia. Ramping position alleviated the obstructive breathing pattern and hypercapnia was subsequently resolved.

Conclusion: There are no available studies on the rule of the ramping position in aiding NIV in obese patients in the ICU. Accordingly, this case series is significantly important in highlighting the possible benefits of the ramping position for obese patients in settings other than anaesthesia.

简介:建议采用倾斜体位,通过改善气道对准,促进肥胖患者麻醉时的预充氧和面罩通气。病例系列的介绍:2例肥胖患者入院重症监护病房(ICU)与2型呼吸衰竭。在无创通气(NIV)下,两例患者均表现为阻塞性呼吸模式,高碳酸血症未能解决。倾斜体位减轻了阻塞性呼吸模式,高碳酸血症随后得到解决。结论:目前尚无关于ICU肥胖患者辅助无创通气时的倾斜体位规律的研究。因此,本病例系列在强调肥胖患者在麻醉以外的环境中采用倾斜体位的可能益处方面具有重要意义。
{"title":"Ramping Position to Aid Non-invasive Ventilation (NIV) in Obese Patients in the ICU.","authors":"Mohamed Shirazy,&nbsp;Christopher Gowers,&nbsp;Padraig Headley","doi":"10.2478/jccm-2023-0002","DOIUrl":"https://doi.org/10.2478/jccm-2023-0002","url":null,"abstract":"<p><strong>Introduction: </strong>The ramping position is recommended to facilitate pre-oxygenation and mask ventilation of obese patients in anaesthetics via improving the airway alignment.</p><p><strong>Presentation of case series: </strong>Two cases of obese patients admitted to the intensive care unit (ICU) with type 2 respiratory failure. Both cases showed obstructive breathing patterns on non-invasive ventilation (NIV) and failed resolution of hypercapnia. Ramping position alleviated the obstructive breathing pattern and hypercapnia was subsequently resolved.</p><p><strong>Conclusion: </strong>There are no available studies on the rule of the ramping position in aiding NIV in obese patients in the ICU. Accordingly, this case series is significantly important in highlighting the possible benefits of the ramping position for obese patients in settings other than anaesthesia.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987266/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9081327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, Practice and Attitudes to the Management of Sepsis in Jamaica. 牙买加败血症管理的知识、实践和态度。
IF 1.1 Pub Date : 2022-10-01 DOI: 10.2478/jccm-2022-0024
Karen Roye-Green, Rohan Willis, Sharon R Priestley, Ivan Vickers

Introduction: Sepsis is a life-threatening dysfunction resulting from the dysregulated host response to infection. The mortality of sepsis in Jamaica remains high amid the proven efficacy of the Surviving Sepsis Guidelines implementation in some countries.

Aim of study: To evaluate the inter-relationship of healthcare workers' attitude towards, knowledge of and practice of sepsis management in Jamaica.

Material and methods: A survey was done using an anonymous self-administered validated questionnaire to healthcare workers across Jamaica. Questions on knowledge, attitude, and practice of sepsis within private and public hospitals were answered.

Results: A total of 616 healthcare workers were eligible for analysis. Most respondents agree that healthcare workers need more training on sepsis (93.7%) and that formal sepsis training modules should be implemented at their hospitals or practice (93.2%). Several signs of sepsis as outlined by qSOFA were correctly identified as such by most respondents (60.6% to 76.4%), with the exception of a low PaCO2 (34.9%), which was correctly identified by a minority of respondents. While a majority (69.3%) were able to correctly define sepsis, only 8.8% of respondents knew the annual sepsis mortality rate. Postgraduate training (p<0.01) and formal sepsis training (p<0.05) were both predictive of high correct knowledge and practice scores. Specialization in Anaesthesia/ Critical Care Medicine (p<0.05) or Emergency Medicine (p<0.05) was predictive of high knowledge scores and Internal Medicine predictive of high practice scores (p<0.01).

Conclusions: This study revealed that education for healthcare workers on sepsis and the implementation of SSC is needed in Jamaica.

败血症是一种危及生命的功能障碍,由宿主对感染的反应失调引起。牙买加的败血症死亡率仍然很高,尽管在一些国家实施《幸存败血症指南》已证明有效。研究目的:评价牙买加卫生保健工作者对败血症管理的态度、知识和实践的相互关系。材料和方法:对牙买加各地的卫生保健工作者进行了一项调查,使用了一份匿名的自我管理的有效问卷。回答了私立和公立医院关于败血症的知识、态度和实践的问题。结果:共有616名医护人员符合分析条件。大多数应答者认为卫生工作者需要更多的败血症培训(93.7%),并认为应在其医院或诊所实施正式的败血症培训模块(93.2%)。大多数应答者(60.6%至76.4%)正确识别了qSOFA概述的脓毒症的几种症状,但少数应答者正确识别了低PaCO2(34.9%)。虽然大多数人(69.3%)能够正确定义败血症,但只有8.8%的受访者知道败血症的年死亡率。研究生培训(结论:本研究表明,教育卫生保健工作者对败血症和SSC的实施是需要在牙买加。
{"title":"Knowledge, Practice and Attitudes to the Management of Sepsis in Jamaica.","authors":"Karen Roye-Green,&nbsp;Rohan Willis,&nbsp;Sharon R Priestley,&nbsp;Ivan Vickers","doi":"10.2478/jccm-2022-0024","DOIUrl":"https://doi.org/10.2478/jccm-2022-0024","url":null,"abstract":"<p><strong>Introduction: </strong>Sepsis is a life-threatening dysfunction resulting from the dysregulated host response to infection. The mortality of sepsis in Jamaica remains high amid the proven efficacy of the Surviving Sepsis Guidelines implementation in some countries.</p><p><strong>Aim of study: </strong>To evaluate the inter-relationship of healthcare workers' attitude towards, knowledge of and practice of sepsis management in Jamaica.</p><p><strong>Material and methods: </strong>A survey was done using an anonymous self-administered validated questionnaire to healthcare workers across Jamaica. Questions on knowledge, attitude, and practice of sepsis within private and public hospitals were answered.</p><p><strong>Results: </strong>A total of 616 healthcare workers were eligible for analysis. Most respondents agree that healthcare workers need more training on sepsis (93.7%) and that formal sepsis training modules should be implemented at their hospitals or practice (93.2%). Several signs of sepsis as outlined by qSOFA were correctly identified as such by most respondents (60.6% to 76.4%), with the exception of a low PaCO2 (34.9%), which was correctly identified by a minority of respondents. While a majority (69.3%) were able to correctly define sepsis, only 8.8% of respondents knew the annual sepsis mortality rate. Postgraduate training (p<0.01) and formal sepsis training (p<0.05) were both predictive of high correct knowledge and practice scores. Specialization in Anaesthesia/ Critical Care Medicine (p<0.05) or Emergency Medicine (p<0.05) was predictive of high knowledge scores and Internal Medicine predictive of high practice scores (p<0.01).</p><p><strong>Conclusions: </strong>This study revealed that education for healthcare workers on sepsis and the implementation of SSC is needed in Jamaica.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682927/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10360679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burnout Syndrome During COVID-19 Second Wave on ICU Caregivers. COVID-19第二波ICU护理人员的职业倦怠综合征
IF 1.1 Pub Date : 2022-10-01 DOI: 10.2478/jccm-2022-0026
Anaëlle Caillet, Marina Fillon, Margaux Plou, Emmanuel Tisson, Charles-Hervé Vacheron, Bernard Allaouchiche

Objective: The main objective of this article is to evaluate the prevalence of burnout syndrome (BOS) among the Intensive Care Unit (ICU) healthcare workers.

Methods: The COVID-impact study is a study conducted in 6 French intensive care units. Five units admitting COVID patient and one that doesn't admit COVID patients. The survey was conducted between October 20th and November 20th, 2020, during the second wave in France. A total of 208 professionals responded (90% response rate). The Maslach Burnout Inventory scale, the Hospital Anxiety and Depression Scale and the Impact of Event Revisited Scale were used to study the psychological impact of the COVID-19 Every intensive care unit worker.

Results: The cohort includes 208 professionals, 52.4% are caregivers. Almost 20% of the respondents suffered from severe BOS. The professionals who are particularly affected by BOS are women, engaged people, nurses or reinforcement, not coming willingly to the intensive care unit and professionals with psychological disorders since COVID-19, those who are afraid of being infected, and people with anxiety, depression or post-traumatic stress disorder. Independent risk factors isolated were being engaged and being a reinforcement. Being a volunteer to come to work in ICU is protective. 19.7% of the team suffered from severe BOS during the COVID-19 pandemic in our ICU. The independent risk factors for BOS are: being engaged (OR = 3.61 (95% CI, 1.44; 9.09), don't working in ICU when it's not COVID-19 pandemic (reinforcement) (OR = 37.71 (95% CI, 3.13; 454.35), being a volunteer (OR = 0.10 (95% CI, 0.02; 0.46).

Conclusion: Our study demonstrates the value of assessing burnout in health care teams. Prevention could be achieved by training personnel to form a health reserve in the event of a pandemic.

目的:本文的主要目的是评估重症监护病房(ICU)医护人员倦怠综合征(BOS)的患病率。方法:新冠肺炎影响研究是在法国6个重症监护病房进行的一项研究。五个接收新冠患者的单位和一个不接收新冠患者的单位。该调查于2020年10月20日至11月20日在法国的第二波期间进行。共有208名专业人士回应(90%的回复率)。采用Maslach倦怠量表、医院焦虑抑郁量表和事件重访影响量表研究新冠肺炎对重症监护病房医护人员的心理影响。结果:队列包括208名专业人员,52.4%为护理人员。近20%的受访者患有严重的BOS。受BOS影响特别严重的专业人员是妇女、受雇人员、护士或不愿意来重症监护室的强化人员、自COVID-19以来患有心理障碍的专业人员、害怕被感染的专业人员以及患有焦虑、抑郁或创伤后应激障碍的人。孤立的独立风险因素正在参与并成为一种强化。作为一名志愿者来ICU工作是一种保护。在2019冠状病毒病大流行期间,我们ICU有19.7%的团队出现了严重的BOS。BOS的独立危险因素是:工作(OR = 3.61 (95% CI, 1.44;9.09),非COVID-19大流行时不要在ICU工作(强化)(OR = 37.71 (95% CI, 3.13;454.35),作为志愿者(OR = 0.10 (95% CI, 0.02;0.46)。结论:本研究证明了医疗团队职业倦怠评估的价值。预防可以通过培训人员在发生大流行时形成卫生储备来实现。
{"title":"Burnout Syndrome During COVID-19 Second Wave on ICU Caregivers.","authors":"Anaëlle Caillet,&nbsp;Marina Fillon,&nbsp;Margaux Plou,&nbsp;Emmanuel Tisson,&nbsp;Charles-Hervé Vacheron,&nbsp;Bernard Allaouchiche","doi":"10.2478/jccm-2022-0026","DOIUrl":"https://doi.org/10.2478/jccm-2022-0026","url":null,"abstract":"<p><strong>Objective: </strong>The main objective of this article is to evaluate the prevalence of burnout syndrome (BOS) among the Intensive Care Unit (ICU) healthcare workers.</p><p><strong>Methods: </strong>The COVID-impact study is a study conducted in 6 French intensive care units. Five units admitting COVID patient and one that doesn't admit COVID patients. The survey was conducted between October 20th and November 20th, 2020, during the second wave in France. A total of 208 professionals responded (90% response rate). The Maslach Burnout Inventory scale, the Hospital Anxiety and Depression Scale and the Impact of Event Revisited Scale were used to study the psychological impact of the COVID-19 Every intensive care unit worker.</p><p><strong>Results: </strong>The cohort includes 208 professionals, 52.4% are caregivers. Almost 20% of the respondents suffered from severe BOS. The professionals who are particularly affected by BOS are women, engaged people, nurses or reinforcement, not coming willingly to the intensive care unit and professionals with psychological disorders since COVID-19, those who are afraid of being infected, and people with anxiety, depression or post-traumatic stress disorder. Independent risk factors isolated were being engaged and being a reinforcement. Being a volunteer to come to work in ICU is protective. 19.7% of the team suffered from severe BOS during the COVID-19 pandemic in our ICU. The independent risk factors for BOS are: being engaged (OR = 3.61 (95% CI, 1.44; 9.09), don't working in ICU when it's not COVID-19 pandemic (reinforcement) (OR = 37.71 (95% CI, 3.13; 454.35), being a volunteer (OR = 0.10 (95% CI, 0.02; 0.46).</p><p><strong>Conclusion: </strong>Our study demonstrates the value of assessing burnout in health care teams. Prevention could be achieved by training personnel to form a health reserve in the event of a pandemic.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10368131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prevalence and Risk Factors of Venous Thromboembolism in Critically Ill Patients with Severe COVID-19 and the Association between the Dose of Anticoagulants and Outcomes. 重症COVID-19危重患者静脉血栓栓塞患病率、危险因素及抗凝剂剂量与预后的关系
IF 1.1 Pub Date : 2022-10-01 DOI: 10.2478/jccm-2022-0023
Hasan M Al-Dorzi, Muhannad Q Alqirnas, Mohamed M Hegazy, Abdullah S Alghamdi, Mohammed T Alotaibi, Mohammed T Albogami, Mohammed M Alhafi, Salem Alwadani, Ashraf Elsharkawi, Yaseen M Arabi

Introduction: COVID-19 is characterized by a procoagulant state that increases the risk of venous and arterial thrombosis. The dose of anticoagulants in patients with severe COVID-19 pneumonia without suspected or confirmed thrombosis has been debated.

Aim of the study: We evaluated the prevalence, predictors, and outcomes of venous thromboembolism (VTE) in critically ill COVID-19 patients and assessed the association between the dose of anticoagulants and outcomes.

Materials and methods: This retrospective cohort included patients with COVID-19 who were admitted to the ICU between March and July 2020. Patients with clinically suspected and confirmed VTE were compared to those not diagnosed to have VTE.

Results: The study enrolled 310 consecutive patients with severe COVID-19 pneumonia: age 60.0±15.1 years, 67.1% required mechanical ventilation and 44.7% vasopressors. Most (97.1%) patients received anticoagulants during ICU stay: prophylactic unfractionated heparin (N=106), standard-dose enoxaparin (N=104) and intermediate-dose enoxaparin (N=57). Limb Doppler ultrasound was performed for 49 (15.8%) patients and chest computed tomographic angiography for 62 (20%). VTE was diagnosed in 41 (13.2%) patients; 20 patients had deep vein thrombosis and 23 had acute pulmonary embolism. Patients with VTE had significantly higher D-dimer on ICU admission. On multivariable Cox regression analysis, intermediate-dose enoxaparin versus standard-dose unfractionated heparin or enoxaparin was associated with lower VTE risk (hazard ratio, 0.06; 95% confidence interval, 0.01-0.74) and lower risk of the composite outcome of VTE or hospital mortality (hazard ratio, 0.42; 95% confidence interval, 0.23-0.78; p=0.006). Major bleeding was not different between the intermediate- and prophylactic-dose heparin groups.

Conclusions: In our study, clinically suspected and confirmed VTE was diagnosed in 13.2% of critically ill patients with COVID-19. Intermediate-dose enoxaparin versus standard-dose unfractionated heparin or enoxaparin was associated with decreased risk of VTE or hospital mortality.

导言:COVID-19的特点是促凝状态,增加静脉和动脉血栓形成的风险。未怀疑或确认血栓形成的COVID-19重症肺炎患者的抗凝剂剂量一直存在争议。研究目的:我们评估了COVID-19危重患者静脉血栓栓塞(VTE)的患病率、预测因素和结局,并评估了抗凝剂剂量与结局之间的关系。材料和方法:本回顾性队列包括2020年3月至7月期间入住ICU的COVID-19患者。将临床怀疑和确诊的静脉血栓栓塞患者与未确诊的静脉血栓栓塞患者进行比较。结果:连续纳入310例重症COVID-19肺炎患者,年龄60.0±15.1岁,67.1%需要机械通气,44.7%需要血管加压药物。大多数(97.1%)患者在ICU住院期间使用抗凝药物:预防性无分离肝素(N=106)、标准剂量依诺肝素(N=104)和中剂量依诺肝素(N=57)。肢体多普勒超声49例(15.8%),胸部ct血管造影62例(20%)。41例(13.2%)患者被诊断为静脉血栓栓塞;深静脉血栓20例,急性肺栓塞23例。静脉血栓栓塞患者入院时d -二聚体明显增高。在多变量Cox回归分析中,中剂量依诺肝素与标准剂量未分离肝素或依诺肝素相比,与较低的静脉血栓栓塞风险相关(风险比,0.06;95%可信区间,0.01-0.74),静脉血栓栓塞或住院死亡的综合结局风险较低(风险比,0.42;95%置信区间为0.23-0.78;p = 0.006)。肝素中剂量组和预防剂量组大出血发生率无差异。结论:在我们的研究中,13.2%的COVID-19危重症患者临床疑似和确诊静脉血栓栓塞。中剂量依诺肝素与标准剂量未分离肝素或依诺肝素相比,与静脉血栓栓塞风险或住院死亡率降低相关。
{"title":"Prevalence and Risk Factors of Venous Thromboembolism in Critically Ill Patients with Severe COVID-19 and the Association between the Dose of Anticoagulants and Outcomes.","authors":"Hasan M Al-Dorzi,&nbsp;Muhannad Q Alqirnas,&nbsp;Mohamed M Hegazy,&nbsp;Abdullah S Alghamdi,&nbsp;Mohammed T Alotaibi,&nbsp;Mohammed T Albogami,&nbsp;Mohammed M Alhafi,&nbsp;Salem Alwadani,&nbsp;Ashraf Elsharkawi,&nbsp;Yaseen M Arabi","doi":"10.2478/jccm-2022-0023","DOIUrl":"https://doi.org/10.2478/jccm-2022-0023","url":null,"abstract":"<p><strong>Introduction: </strong>COVID-19 is characterized by a procoagulant state that increases the risk of venous and arterial thrombosis. The dose of anticoagulants in patients with severe COVID-19 pneumonia without suspected or confirmed thrombosis has been debated.</p><p><strong>Aim of the study: </strong>We evaluated the prevalence, predictors, and outcomes of venous thromboembolism (VTE) in critically ill COVID-19 patients and assessed the association between the dose of anticoagulants and outcomes.</p><p><strong>Materials and methods: </strong>This retrospective cohort included patients with COVID-19 who were admitted to the ICU between March and July 2020. Patients with clinically suspected and confirmed VTE were compared to those not diagnosed to have VTE.</p><p><strong>Results: </strong>The study enrolled 310 consecutive patients with severe COVID-19 pneumonia: age 60.0±15.1 years, 67.1% required mechanical ventilation and 44.7% vasopressors. Most (97.1%) patients received anticoagulants during ICU stay: prophylactic unfractionated heparin (N=106), standard-dose enoxaparin (N=104) and intermediate-dose enoxaparin (N=57). Limb Doppler ultrasound was performed for 49 (15.8%) patients and chest computed tomographic angiography for 62 (20%). VTE was diagnosed in 41 (13.2%) patients; 20 patients had deep vein thrombosis and 23 had acute pulmonary embolism. Patients with VTE had significantly higher D-dimer on ICU admission. On multivariable Cox regression analysis, intermediate-dose enoxaparin versus standard-dose unfractionated heparin or enoxaparin was associated with lower VTE risk (hazard ratio, 0.06; 95% confidence interval, 0.01-0.74) and lower risk of the composite outcome of VTE or hospital mortality (hazard ratio, 0.42; 95% confidence interval, 0.23-0.78; p=0.006). Major bleeding was not different between the intermediate- and prophylactic-dose heparin groups.</p><p><strong>Conclusions: </strong>In our study, clinically suspected and confirmed VTE was diagnosed in 13.2% of critically ill patients with COVID-19. Intermediate-dose enoxaparin versus standard-dose unfractionated heparin or enoxaparin was associated with decreased risk of VTE or hospital mortality.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10360675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiological Monitoring - A Cornerstone for Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 Outcome: A Case Report and a Review from the Literature. 心脏病监测-与COVID-19结果暂时相关的儿童炎症多系统综合征的基础:一个病例报告和文献综述
IF 1.1 Pub Date : 2022-10-01 DOI: 10.2478/jccm-2022-0022
Lorena Elena Melit, Oana Marginean, Tudor Fleșeriu, Alina Negrea, Maria Oana Săsăran, Simina Ghiraghosian-Rusu, Andrei Călin Dragomir, Mirela Oiaga, Carmen Șuteu

Introduction: Pediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS) is a rare life-threatening condition requiring a complex management and multidisciplinary approach, whose outcome depends on the early diagnosis.

Case report: We report the case of a 2 years and-5-month-old boy admitted in our clinic for fever, abdominal pain and diarrhea. The clinical exam at the time of admission revealed influenced gen-eral status, bilateral palpebral edema and conjunctivitis, mucocutaneous signs of dehydration, and abdominal tenderness at palpation. The laboratory tests performed pointed out lymphopenia, thrombocytopenia, anemia, elevated C-reactive protein - CRP, erythrocyte sedimentation rate and ferritin levels, hyponatremia, hypopotassemia, hypertriglyceridemia, elevated D-dimer, in-creased troponin and NT-proBNP. The real-time polymerase chain reaction (RT-PCR) test for SARS-CoV-2 infection was negative, but the serology was positive. Thus, established the diagnosis of PIMS-TS. We initiated intravenous immunoglobulin, empirical antibiotic, anticoagulation therapy and symptomatic drugs. Nevertheless, the clinical course and laboratory parameters worsened, and the 2nd echocardiography pointed out minimal pericardial effusion, slight dilation of the left cavities, dyskinesia of the inferior and septal basal segments of the left ventricle (LV), and LV systolic dysfunction. Therefore, we associated intravenous methylprednisolone, angiotensin converting enzyme inhibitors, spironolactone and hydrochlorothiazide, with outstanding favorable evolution.

Conclusions: Echocardiographic monitoring might be a lifesaving diagnostic tool in the management of PIMS-TS.

儿童与COVID-19暂时相关的炎症性多系统综合征(PIMS-TS)是一种罕见的危及生命的疾病,需要复杂的治疗和多学科方法,其预后取决于早期诊断。病例报告:我们报告一例2岁零5个月的男孩在我们的诊所入院发烧,腹痛和腹泻。入院时的临床检查显示全身受影响,双侧眼睑水肿和结膜炎,粘膜皮肤脱水征象,触诊腹部压痛。实验室检查指出淋巴细胞减少、血小板减少、贫血、c反应蛋白- CRP升高、红细胞沉降率和铁蛋白水平升高、低钠血症、低钾血症、高甘油三酯血症、d -二聚体升高、肌钙蛋白和NT-proBNP升高。实时聚合酶链反应(RT-PCR)检测SARS-CoV-2感染阴性,血清学阳性。从而确立了PIMS-TS的诊断。我们开始静脉注射免疫球蛋白、经验性抗生素、抗凝治疗和对症用药。然而,临床病程和实验室参数恶化,第二次超声心动图提示少量心包积液,左腔轻度扩张,左心室下段和间隔基段运动障碍,左室收缩功能障碍。因此,我们将静脉注射甲基强的松龙、血管紧张素转换酶抑制剂、螺内酯和氢氯噻嗪与突出的有利进化联系起来。结论:超声心动图监测可能是一种挽救PIMS-TS生命的诊断工具。
{"title":"Cardiological Monitoring - A Cornerstone for Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 Outcome: A Case Report and a Review from the Literature.","authors":"Lorena Elena Melit,&nbsp;Oana Marginean,&nbsp;Tudor Fleșeriu,&nbsp;Alina Negrea,&nbsp;Maria Oana Săsăran,&nbsp;Simina Ghiraghosian-Rusu,&nbsp;Andrei Călin Dragomir,&nbsp;Mirela Oiaga,&nbsp;Carmen Șuteu","doi":"10.2478/jccm-2022-0022","DOIUrl":"https://doi.org/10.2478/jccm-2022-0022","url":null,"abstract":"<p><strong>Introduction: </strong>Pediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS) is a rare life-threatening condition requiring a complex management and multidisciplinary approach, whose outcome depends on the early diagnosis.</p><p><strong>Case report: </strong>We report the case of a 2 years and-5-month-old boy admitted in our clinic for fever, abdominal pain and diarrhea. The clinical exam at the time of admission revealed influenced gen-eral status, bilateral palpebral edema and conjunctivitis, mucocutaneous signs of dehydration, and abdominal tenderness at palpation. The laboratory tests performed pointed out lymphopenia, thrombocytopenia, anemia, elevated C-reactive protein - CRP, erythrocyte sedimentation rate and ferritin levels, hyponatremia, hypopotassemia, hypertriglyceridemia, elevated D-dimer, in-creased troponin and NT-proBNP. The real-time polymerase chain reaction (RT-PCR) test for SARS-CoV-2 infection was negative, but the serology was positive. Thus, established the diagnosis of PIMS-TS. We initiated intravenous immunoglobulin, empirical antibiotic, anticoagulation therapy and symptomatic drugs. Nevertheless, the clinical course and laboratory parameters worsened, and the 2nd echocardiography pointed out minimal pericardial effusion, slight dilation of the left cavities, dyskinesia of the inferior and septal basal segments of the left ventricle (LV), and LV systolic dysfunction. Therefore, we associated intravenous methylprednisolone, angiotensin converting enzyme inhibitors, spironolactone and hydrochlorothiazide, with outstanding favorable evolution.</p><p><strong>Conclusions: </strong>Echocardiographic monitoring might be a lifesaving diagnostic tool in the management of PIMS-TS.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10360674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1